Old Web
English
Sign In
Acemap
>
Paper
>
16PODM-207: A novel BET bromodomain inhibitor with antitumor activity in nonclinical models of ER+ breast cancer
16PODM-207: A novel BET bromodomain inhibitor with antitumor activity in nonclinical models of ER+ breast cancer
2018
Anu-Maarit Moilanen
J Lindqvist
M. Björkman
Reetta Riikonen
Daniel Nicorici
E Mattila
Chandrasekhar Abbineni
Mahaboobi Jaleel
John E. Eriksson
Pekka Kallio
Keywords:
Breast cancer
Pathology
Medicine
Cancer research
Bromodomain
er breast cancer
antitumor activity
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]